[Dermatologists facing the risk of viral transmission. Analysis of the precautionary measures of 472 practitioners].
On the occasion of the "Journées Dermatologiques de Paris", in March 1988 we designed a survey to evaluate the sterile practices of French dermatologists in the "AIDS era". During the two days meeting, attended by 2,584 participants, 472 questionnaire forms were filled in (answer rate 18.5 p. 100). Among responders 43 p. 100 were exclusively office-based, 13 p. 100 only worked in hospitals, and 44 p. 100 were practicing both in office and hospital. The overall utilisation of gloves by French dermatologists remained highly variable, depending on the procedure. For example 6.7 p. 100 of responders reported never using gloves for excisions, 13 p. 100 for shave biopsies, 18 p. 100 for punch biopsies, 40 p. 100 for curettage and 47 p. 100 for electrocoagulation. Five per cent of the dermatologists surveyed did not sterilize their curettes regularly and 42 p. 100 their electrocoagulation needles. Heat sterilization was the most commonly used, in 69 p. 100 of cases for curettes and 42 p. 100 for electrocoagulation needles. On the other hand, chemical tray sterilization was used in 58 p. 100 of the cases for electrocoagulation needles, and in 31 p. 100 for curettes. For chemical sterilization, 63 p. 100 of responders used alcohol, 15 p. 100 glutaraldehyde, 15 p. 100 sodium hydrochloride, and 7 p. 100 other agents, mainly quartenary ammonium compounds. Twelve per cent of the physicians surveyed have adopted the practice of using a single electrocoagulation needle, belonging to each patient, for long term repeated procedures.(ABSTRACT TRUNCATED AT 250 WORDS)
Service de Dermatologie, Hôpital Henri-Mondor, Université Paris XII, Créteil.
E
E
Caumes
M
M
Baspeyras
R
R
Touraine
J C
JC
Roujeau
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control / Q000635:transmission; D003880:Dermatology; D004203:Disinfection / Q000379:methods; D005602:France; D005932:Gloves, Surgical; D006509:Hepatitis B / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D009339:Needles; D011482:Protective Devices; D012306:Risk; D011795:Surveys and Questionnaires; D014761:Viral Hepatitis Vaccines; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission*
D014761:Viral Hepatitis Vaccines
Les dermatologues face au risque de transmission virale. Analyse des précautions prises par 472 praticiens.